相关实验视频

Updated: May 13, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

尼日利亚东北部常见的血液性恶性瘤:对其模式,分布和治疗的多中心研究提出了挑战

Rufai Abdu Dachi¹, Falmata Grema Mustapha¹, Jesini James²

¹Department of Haematology and Blood Transfusion, Abubakar Tafawa Balewa University, Bauchi, Bauchi, Nigeria.

Frontiers in oncology

|April 15, 2025

概括

血质性恶性瘤在尼日利亚东北部普遍存在,有限的资源阻碍了诊断和治疗. 这项研究强调了管理该地区这些血液癌症的负担和挑战.

科学领域:

在瘤学瘤学.
血液学血液学血液学
公共卫生公共卫生

背景情况:

血液性恶性瘤 (HM) 构成了全球严重的健康负担,其特点是不同的临床表现和预后.
尼日利亚东北部面临着高贫困率和有限的医疗保健基础设施的双重挑战,加剧了HMS的影响.
在这个服务不足的地区,迫切需要有关卫生病的流行病学和管理的全面数据.

研究的目的:

确定尼日利亚东北部常见的血液性恶性瘤的多中心负担.
分析该地区与HM相关的分配模式和管理挑战.
提供可以为医疗保健政策和癌症护理资源分配提供信息的数据.

主要方法:

一项为期5年的回顾性研究 (2018年1月 - 2022年12月) 在尼日利亚东北部的四个主要医疗机构进行.
收集和分析了患者人口统计,诊断和HM亚型的数据.
使用SPSS 23.0.0版本进行统计分析.

主要成果:

总共有493例HMS被诊断出,占所有癌症的8.2%.
儿科保健医生占病例的42.0%. 非霍奇金淋巴瘤 (NHL) 是最常见的 (23.5%),而多发性骨髓瘤 (MM) 是最不常见的 (7.7%).
显著的挑战包括迟到的呈现,人员短缺,治疗的财务限制,以及对先进的诊断设施 (流细胞计,免疫组织化学,细胞遗传学) 的有限访问.

结论:

血液性恶性瘤是尼日利亚东北部的重大健康问题.
由于资源和专业知识有限,该地区在准确诊断和有效治疗HM方面面临重大挑战.
医疗保健基础设施和专业服务的紧急改善是必要的,以应对不断增长的血液癌症负担.

关键词:

尼日利亚东北部挑战挑战挑战挑战挑战分销销售分销销售分销销售血液学恶性瘤血液学恶性瘤模式模式模式模式模式

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...